KARO

Karo Pharma

Market Cap 3,048.4M
Today
Day High
37.40
37.1
Day Low
36.60
Day Open
36.90
Prev Close
37.10
VWAP
37.0
Volume
105K
Turnover
3.883M
Top Broker
VWAP
37.0
Avg Volume
153K
Avg Turnover
5.673M
Top Brokers
AVA/SWB
VWAP
35.8
Avg Volume
266K
Avg Turnover
9.501M
Top Brokers
AVA/NON
VWAP
36.7
Avg Volume
238K
Avg Turnover
8.724M
Top Brokers
AVA/NON
52 week summary
Price Range
24.0
Last
46.8
Beta
N/A
Market Cap
3,048.4M
Total Return
27.1%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
82.2M
Next Earnings Date
22 Feb
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months -18.5%
Change 12 Months 14.4%
Volume Trend
Average Volume 10 vs 60 Days 13.2%
Price VS
52 Week High -20.7%
50 Day Moving Average -2.7%
200 Day moving Average -7.0%

Add article markers

Compare Karo Pharma to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Peter Blom, CEO
  • Executive board
  • Anders Lönner, Chairman of the board
Source: Millistream
Major Owners Equity Votes
Anders Lönner 7.9%
7.9%
Försäkringsaktiebolaget, Avanza Pension 7.7%
7.7%
JP Morgan Bank 4.0%
4.0%
Nordnet Pensionsförsäkring AB 3.2%
3.2%
Nomic AB 2.6%
2.6%
Source: Millistream
Timeframe Transactions Net Shares
Last 12 weeks
8 Purchases
+ 80,000
0 Sales
- 0
Last 24 weeks
8 Purchases
+ 80,000
0 Sales
- 0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.